|
Oct 1
|
MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall
|
|
Aug 29
|
MiMedx Group (NASDAQ:MDXG) shareholders have endured a 56% loss from investing in the stock three years ago
|
|
Aug 26
|
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT
|
|
Jul 31
|
MiMedx: Q2 Earnings Snapshot
|
|
Jul 31
|
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
|
|
Jul 31
|
MIMEDX Announces Second Quarter 2024 Operating and Financial Results
|
|
Jul 29
|
MDXG: Final Note Before Wednesday’s Earnings
|
|
Jul 1
|
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
|
|
Jun 26
|
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
|
|
Jun 24
|
With 45% ownership, MiMedx Group, Inc. (NASDAQ:MDXG) has piqued the interest of institutional investors
|
|
May 15
|
MIMEDX to Participate in Upcoming Investor Conferences
|
|
May 2
|
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
|
|
May 1
|
Q1 2024 MiMedx Group Inc Earnings Call
|
|
May 1
|
MDXG: MACs Give Credit for Efficacy
|
|
May 1
|
MiMedx Group Inc (MDXG) Q1 2024 Earnings Call Transcript Highlights: Strong Financial ...
|
|
Apr 30
|
MIMEDX Announces First Quarter 2024 Operating and Financial Results
|
|
Apr 16
|
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
|
|
Apr 11
|
MDXG: Legal Avenues
|
|
Mar 27
|
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
|
|
Mar 21
|
Investing in MiMedx Group (NASDAQ:MDXG) a year ago would have delivered you a 138% gain
|